Novartis Investigative Site

Komatsushimachō, Tokushima 773-8502

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Chronic Heart Failure

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed